Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack-March 2024-www.financetom.com

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Nov 27, 2024 4:25 AM

Nov 27 (Reuters) - Canada's public health agency has

approved Novo Nordisk's weight loss drug Wegovy to

reduce the risk of nonfatal myocardial infarction, or heart

attack, in adults with established cardiovascular disease, the

drugmaker said on Wednesday.

Previous page： Melcor REIT Concludes 'Go Shop' Period and Sells Grande Prairie Property in Alberta Next page： Why Wah Fu Education Group (WAFU) Stock Is Surging

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Melcor REIT Concludes 'Go Shop' Period and Sells Grande Prairie Property in Alberta

Feb 25, 2025

09:56 AM EST, 02/25/2025 (MT Newswires) -- Melcor Real Estate Investment Trust (MR-UN.TO) on Tuesday said the 90 day go-shop period provided as part of a previously announced agreement expired without the arrival of a superior offer. As part of the deal, Melcor Developments ( MODVF ) will buy the 45% it doesn't already own of Melcor REIT LP for...

Why Wah Fu Education Group (WAFU) Stock Is Surging

Feb 25, 2025

Wah Fu Education Group Ltd ( WAFU ) shares are trading higher by 213.9% to $5.83 during Tuesday’s session after the company announced it will integrate DeepSeek to drive AI-based education innovation and long-term growth strategies. What To Know: Wah Fu Education ( WAFU ) on Tuesday announced its full integration of the DeepSeek large language model. The company says...

Soccer-Lack of success a key factor in Man Utd's financial troubles, says Amorim

Feb 25, 2025

Feb 25 (Reuters) - Manchester United's ( MANU ) lack of success in recent years is a contributing factor in the Premier League club's financial struggles, manager Ruben Amorim said on Tuesday, stressing the importance of quickly improving performances on the pitch. On Monday, United announced they would cut 150-200 jobs as part of an overhaul to return to profitability...

Natera's Signatera Lung Cancer Test Meets Medicare Coverage Requirements

Feb 25, 2025

09:53 AM EST, 02/25/2025 (MT Newswires) -- Natera ( NTRA ) said Tuesday that its Signatera test for patients diagnosed with lung cancer has met coverage requirements for the Centers for Medicare & Medicaid Services' Molecular Diagnostics Services Program. The company said the coverage is intended for patients with non-small cell lung cancer, specifically patients with stage 1 through stage...